Cantor Fitzgerald sets GH Research stock Overweight, $14 target
GH Research PLC (NASDAQ:GHRS) has received an Overweight rating from Cantor Fitzgerald, with a price target set at $14.00. The new coverage is based on the potential of GHRS's GH001, an inhaled ...
GH Research initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan initiated coverage of GH Research (GHRS) with an Overweight rating and no price target GH Research is ...
‘I’m just a seeker’: The Sydney mum who spent a year sampling psychedelics
Sarah Napthali lowers her voice over lunch when our conversation veers to the names of the drugs she used: LSD, MDMA, ...